Hi Tangent.
I'm specifically talking of the launch, as that seems to me the only sizeable source of cash flow currently in prospect.
As to present outflows, the most recent accounts indicated cash was disappearing at about that rate, with only minimal inflows last year. That may well have increased this year, but surely not to an extent to make a huge basic difference.
I they had to defer OXY, that would surely be a major setback?
I'm sure they could raise more funds. But so soon, it would signal a major setback in plans, would be on a long term prospectus (OXY $30 million to develop, 2-3 years time, no certainty) & they'd inevitably be screwed big time on price. Major dilution for current shareholders inevitable, I suggest.
Disappointment, like you, if 'Ferrari' hopes don't work out, but I'd settle for say 300% turn (40c) with a reasonable satisfaction..... And many others would do even better, including some big holdings who might have a few words to say to the Board...
- Forums
- ASX - By Stock
- the positive side if elixia launch ?fails?
AVE
avecho biotechnology limited
Add to My Watchlist
12.5%
!
0.4¢

Hi Tangent. I'm specifically talking of the launch, as that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $453 | 129.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 33486086 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 8328117 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 32986086 | 0.003 |
15 | 16879866 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 8218985 | 6 |
0.005 | 13262502 | 18 |
0.006 | 31623747 | 5 |
0.007 | 4498187 | 12 |
0.008 | 4722624 | 6 |
Last trade - 13.52pm 04/07/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online